Bioregenx annual revenue
2021
2022
2023
2024
2025
Bioregenx Revenue Growth & History (BRGX)
Bioregenx reported $1.9M in revenue for fiscal 2025, a decrease of 20.75% from the previous fiscal year.
View full Bioregenx company overviewBioregenx annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.9M | −$485,593 | −20.75% |
| 2024 | 2024-12-31 | $2.3M | −$1.1M | −31.40% |
| 2023 | 2023-12-31 | $3.4M | $3.4M | +7991.78% |
| 2022 | 2022-12-31 | $42,159 | −$156,425 | −78.77% |
| 2021 | 2021-12-31 | $198,584 | — | — |
Bioregenx quarterly revenue
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $426,175 | −$88,972 | −17.27% |
| Q4 2025 | 2025-12-31 | $385,641 | −$74,848 | −16.25% |
| Q3 2025 | 2025-09-30 | $507,755 | −$88,282 | −14.81% |
| Q2 2025 | 2025-06-30 | $445,970 | −$288,062 | −39.24% |
| Q1 2025 | 2025-03-31 | $515,147 | −$34,401 | −6.26% |
| Q4 2024 | 2024-12-31 | $460,489 | −$217,519 | −32.08% |
| Q3 2024 | 2024-09-30 | $596,037 | −$198,507 | −24.98% |
| Q2 2024 | 2024-06-30 | $734,032 | −$129,246 | −14.97% |
| Q1 2024 | 2024-03-31 | $549,548 | −$526,037 | −48.91% |
| Q4 2023 | 2023-12-31 | $678,008 | $669,094 | +7506.10% |
| Q3 2023 | 2023-09-30 | $794,544 | $783,261 | +6941.96% |
| Q2 2023 | 2023-06-30 | $863,278 | $849,020 | +5954.69% |
| Q1 2023 | 2023-03-31 | $1.1M | $1.1M | +13861.38% |
| Q4 2022 | 2022-12-31 | $8,914 | — | — |
| Q3 2022 | 2022-09-30 | $11,283 | — | — |
| Q2 2022 | 2022-06-30 | $14,258 | — | — |
| Q1 2022 | 2022-03-31 | $7,704 | — | — |
Bioregenx revenue growth trends
Bioregenx's latest reported quarter, Q1 2026, generated $426,175 in revenue, a decrease of 17.27% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Bioregenx source filings ↗